190 related articles for article (PubMed ID: 18555897)
1. A PEACE-ful solution to COPD exacerbations?
Albert P; Calverley P
Lancet; 2008 Jun; 371(9629):1975-6. PubMed ID: 18555897
[No Abstract] [Full Text] [Related]
2. Carbocisteine for acute exacerbations of COPD.
Mohapatra PR; Aggarwal D
Lancet; 2008 Nov; 372(9650):1630-1; author reply 1631-2. PubMed ID: 18994656
[No Abstract] [Full Text] [Related]
3. Carbocisteine for acute exacerbations of COPD.
Waller P; Suissa S
Lancet; 2008 Nov; 372(9650):1630; author reply 1631-2. PubMed ID: 18994655
[No Abstract] [Full Text] [Related]
4. Carbocisteine improves quality of life in patients with chronic obstructive pulmonary disease.
Tatsumi K; Fukuchi Y;
J Am Geriatr Soc; 2007 Nov; 55(11):1884-6. PubMed ID: 17979906
[No Abstract] [Full Text] [Related]
5. Effect of carbocisteine on acute exacerbation of chronic obstructive pulmonary disease (PEACE Study): a randomised placebo-controlled study.
Zheng JP; Kang J; Huang SG; Chen P; Yao WZ; Yang L; Bai CX; Wang CZ; Wang C; Chen BY; Shi Y; Liu CT; Chen P; Li Q; Wang ZS; Huang YJ; Luo ZY; Chen FP; Yuan JZ; Yuan BT; Qian HP; Zhi RC; Zhong NS
Lancet; 2008 Jun; 371(9629):2013-8. PubMed ID: 18555912
[TBL] [Abstract][Full Text] [Related]
6. Interventions to reduce the frequency of exacerbations of chronic obstructive pulmonary disease.
Black PN; McDonald CF
Postgrad Med J; 2009 Mar; 85(1001):141-7. PubMed ID: 19351641
[TBL] [Abstract][Full Text] [Related]
7. Chronic obstructive pulmonary disease.
Kerstjens H; Postma D; ten Hacken N
Clin Evid; 2006 Jun; (15):2077-100. PubMed ID: 16973079
[No Abstract] [Full Text] [Related]
8. Efficacy and safety profile of mucolytic/antioxidant agents in chronic obstructive pulmonary disease: a comparative analysis across erdosteine, carbocysteine, and N-acetylcysteine.
Rogliani P; Matera MG; Page C; Puxeddu E; Cazzola M; Calzetta L
Respir Res; 2019 May; 20(1):104. PubMed ID: 31133026
[TBL] [Abstract][Full Text] [Related]
9. Impact of Mucolytic Agents on COPD Exacerbations: A Pair-wise and Network Meta-analysis.
Cazzola M; Rogliani P; Calzetta L; Hanania NA; Matera MG
COPD; 2017 Oct; 14(5):552-563. PubMed ID: 28753070
[TBL] [Abstract][Full Text] [Related]
10. Effect of CArbocisteine in Prevention of exaceRbation of chronic obstructive pulmonary disease (CAPRI study): An observational study.
Esposito A; Valentino MR; Bruzzese D; Bocchino M; Ponticiello A; Stanziola A; Sanduzzi A
Pulm Pharmacol Ther; 2016 Apr; 37():85-8. PubMed ID: 26970503
[TBL] [Abstract][Full Text] [Related]
11. [Chronic obstructive pulmonary disease exacerbation. Do we use all possibilities of outpatient therapy?].
Leshchenko IV
Ter Arkh; 2013; 85(10):83-7. PubMed ID: 24437224
[TBL] [Abstract][Full Text] [Related]
12. Prediction and prevention of exacerbations and mortality in patients with COPD.
Kostikas K; Clemens A; Patalano F
Expert Rev Respir Med; 2016 Jul; 10(7):739-53. PubMed ID: 27135786
[TBL] [Abstract][Full Text] [Related]
13. [Other drugs (not bronchodilators) in COPD].
García Río F
Arch Bronconeumol; 2004 Mar; 40 Suppl 1():34-40. PubMed ID: 16137448
[No Abstract] [Full Text] [Related]
14. Treatment of chronic obstructive pulmonary disease.
Ziment I; Yick D
J Am Med Dir Assoc; 2003; 4(5 Suppl):S121-6. PubMed ID: 14501809
[No Abstract] [Full Text] [Related]
15. Acute exacerbations of chronic obstructive pulmonary disease.
Palm KH; Decker WW
Emerg Med Clin North Am; 2003 May; 21(2):331-52, viii. PubMed ID: 12793617
[TBL] [Abstract][Full Text] [Related]
16. Reducing airways inflammation to prevent exacerbations in chronic obstructive pulmonary disease.
Roche N; Huchon G
Allergy; 2005 Nov; 60(11):1350-6. PubMed ID: 16197465
[No Abstract] [Full Text] [Related]
17. Exacerbations of chronic obstructive pulmonary disease.
Wedzicha JA; Donaldson GC
Respir Care; 2003 Dec; 48(12):1204-13; discussion 1213-5. PubMed ID: 14651761
[TBL] [Abstract][Full Text] [Related]
18. Chronic obstructive pulmonary disease.
Kerstjens H; Postma D
Clin Evid; 2002 Dec; (8):1530-45. PubMed ID: 12603952
[No Abstract] [Full Text] [Related]
19. Prevention of exacerbations of COPD with pharmacotherapy.
Miravitlles M
Eur Respir Rev; 2010 Jun; 19(116):119-26. PubMed ID: 20956180
[TBL] [Abstract][Full Text] [Related]
20. [Toward personalized and integrated treatment of patients with COPD].
Ancochea J; Gómez García T; de Miguel Díez J
Arch Bronconeumol; 2010 Dec; 46 Suppl 10():14-8. PubMed ID: 21316551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
